(ABM FN) The Brussels stock market had another lackluster session on Thursday, with the Bel20 still rising 0.3 percent to 3,845.63 points. With these profits, investors can start the Easter weekend.
Investors remained cautious ahead of tomorrow’s release of the PCE inflation index for February, fearing an unpleasant surprise in the form of a higher-than-expected price increase.
It should be noted that investors also digested the hawkish comments from Fed Governor Christopher Waller on Wednesday evening, who sees no reason to pressure the Fed to cut rates as the US labor market in particular remains solid.
His comments visibly pushed the euro below $1.08, while US 10-year yields rose.
American growth reached 3.4 percent last quarter, after an increase of 4.9 percent in the third quarter. Economists had expected growth of 3.2 percent.
The oil price rose by 1.4 percent in the early evening to more than $ 87 per barrel Brent.
Risers and fallers
Lotus Bakeries rose 3.6 percent and thus delivered the best price performance. The cookie manufacturer was helped by Bank of America, which started monitoring the stock with a buy recommendation and a price target of 10,500 euros.
Cofinimmo gained 2.6 percent, while Galapagos fell 2.5 percent and finished at the bottom.
Outside the main index, DEME was the star with a price gain of 5.4 percent, after Kepler Cheuvreux significantly increased the price target for DEME to 170 euros.
Euronav rose by 1.7 percent after KBC Securities resumed monitoring the shipping company with a buy recommendation.
IBA caught its breath after a 9 percent jump yesterday and fell 0.2 percent.
Among the small stocks, Belysse rose 12 percent and Unifiedpost 9.6 percent, while Sequana Medical lost 3.5 percent.
This morning, the medtech company confirmed that it still has sufficient resources until the end of the third quarter of 2024. There are therefore doubts whether continuity can be maintained. The company, on the other hand, has received feedback from the US FDA on its alfapump PMA application. A meeting is scheduled with the FDA on April 9, 2024.
Mithra has filed for protection against its creditors while it is in the process of selling off operations. The publication of the figures has been postponed from April 16 to April 30 and the annual meeting from May 16 to May 30. Mithra posted a gain of 3.1 percent.
Wall Street
At the end of the Brussels trading day, the American stock markets were around Wednesday’s closing prices.
Source: ABM Financial News
ABM Financial News is a supplier of stock market news, video and data, both for real-time trading platforms and dealing rooms and for online and offline media publications. The information in this article is not intended as professional investment advice or as a recommendation to make certain investments.
Community trend
Will the stock rise or fall following this news item?
Community trend
You must be logged in to perform this action. Log in or Sign up
